IMIPRAMINE PAMOATE - Generic Drug Details

✉ Email this page to a colleague

What are the generic drug sources for imipramine pamoate and what is the scope of freedom to operate?

Imipramine pamoate is the generic ingredient in two branded drugs marketed by Hikma, Lupin Ltd, Rising, and Specgx Llc, and is included in four NDAs. Additional information is available in the individual branded drug profile pages.

There are nine drug master file entries for imipramine pamoate. Two suppliers are listed for this compound.

Summary for IMIPRAMINE PAMOATE

US Patents:	0
Tradenames:	2
Applicants:	4
NDAs:	4
Drug Master File Entries:	9
Finished Product Suppliers / Packagers:	2
Raw Ingredient (Bulk) Api Vendors:	14
Clinical Trials:	2
Patent Applications:	3
Drug Prices:	Drug price trends for IMIPRAMINE PAMOATE
What excipients (inactive ingredients) are in IMIPRAMINE PAMOATE?	IMIPRAMINE PAMOATE excipients list
DailyMed Link:	IMIPRAMINE PAMOATE at DailyMed

See drug prices for IMIPRAMINE PAMOATE

Recent Clinical Trials for IMIPRAMINE PAMOATE

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
Shalvata Mental Health Center	N/A
Roxane Laboratories	N/A

See all IMIPRAMINE PAMOATE clinical trials

Pharmacology for IMIPRAMINE PAMOATE

Drug Class	Tricyclic Antidepressant

Anatomical Therapeutic Chemical (ATC) Classes for IMIPRAMINE PAMOATE

N06AA	Non-selective monoamine reuptake inhibitors
N06A	ANTIDEPRESSANTS
N06	PSYCHOANALEPTICS
N	Nervous system

US Patents and Regulatory Information for IMIPRAMINE PAMOATE

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Specgx Llc	TOFRANIL-PM	imipramine pamoate	CAPSULE;ORAL	017090-001	Approved Prior to Jan 1, 1982		DISCN	Yes	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Specgx Llc	TOFRANIL-PM	imipramine pamoate	CAPSULE;ORAL	017090-004	Approved Prior to Jan 1, 1982		DISCN	Yes	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Lupin Ltd	IMIPRAMINE PAMOATE	imipramine pamoate	CAPSULE;ORAL	090444-003	Apr 16, 2010	AB	RX	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.